ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DNA Ginkgo Bioworks Holdings Inc

0.6595
-0.0415 (-5.92%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Ginkgo Bioworks Holdings Inc NYSE:DNA NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0415 -5.92% 0.6595 0.7199 0.6511 0.7199 85,754,499 01:00:00

Ginkgo Bioworks Announces Date of Second Quarter 2022 Results Presentation

08/08/2022 1:50pm

PR Newswire (US)


Ginkgo Bioworks (NYSE:DNA)
Historical Stock Chart


From May 2022 to May 2024

Click Here for more Ginkgo Bioworks Charts.

Presentation and Q&A session scheduled for post-market on Monday, August 15, 2022

BOSTON, Aug. 8, 2022 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced today that it plans to host a presentation and Q&A session reviewing business performance for the second quarter ended June 30, 2022, on Monday, August 15, 2022, beginning at 4:30 p.m. ET.

(PRNewsfoto/Ginkgo Bioworks)

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit https://www.ginkgobioworks.com/.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com     

MEDIA CONTACT:

press@ginkgobioworks.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2022-results-presentation-301601471.html

SOURCE Ginkgo Bioworks

Copyright 2022 PR Newswire

1 Year Ginkgo Bioworks Chart

1 Year Ginkgo Bioworks Chart

1 Month Ginkgo Bioworks Chart

1 Month Ginkgo Bioworks Chart

Your Recent History

Delayed Upgrade Clock